The Change of the Detrusor Thickness After Hypospadias Repair - Comparison With the Normal Control Group

Hypospadias Clinical Trial

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01762007
• Other study ID #: 4-2012-0372
• Status: Withdrawn
• Start date: November 2012
• Est. completion date: July 2013

Study information

• Verified date: May 2021
• Source: Yonsei University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Even successfully managed hypospadias without any complication, voiding problem could be developed due to the increased urethral resistance. The investigators are trying to analyze the effect of hypospadias operation on voiding function by checking the detrusor thickness and urinary nerve growth factor.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: N/A to 5 Years

Eligibility

Inclusion Criteria:

<Group 1>

1. 6Mo-2Yr old penile hypospadias patients before operation <Group 2>

2. 6Mo-2Yr old male patients without hypospadias <Group 3>

3. penile hypospadias patients under the age of 5 Yr who got tubularized incised plate operation at out institution at the age between 6Mo and 2Yr old and more than 1 Yr have passed <Group 4>

4. 2Yr-5Yr old male patients without hypospadias1. 0-3 year old children without any abnormality of urinary tract

Exclusion Criteria:

<Group 1, 2, 4>

1. patients with history of urethral operation, febrile urinary tract infection, neurogenic abnormality om operation <Group 3>

1. patients with history of urethral operation other than hypospadias repair, febrile urinary tract infection, neurogenic abnormality

2. patients with development urethra-cutaneous fistula

Related Conditions & MeSH terms

• Hypospadias

Locations

Country	Name	City	State
Korea, Republic of	Sang Won	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detrusor thickness		immediate analysis of detrusor thickness at the enrollment time of this study
Secondary	urinary nerve growth factor level		immediate analysis of urinary nerve growth factor level at the enrollment time of this study